CenterBook Partners LP Has $9.13 Million Stock Position in Establishment Labs Holdings Inc. $ESTA

CenterBook Partners LP lessened its position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 41.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 222,845 shares of the company’s stock after selling 156,540 shares during the quarter. CenterBook Partners LP owned about 0.77% of Establishment Labs worth $9,134,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. State of Wyoming bought a new stake in Establishment Labs during the 3rd quarter worth about $71,000. Osaic Holdings Inc. grew its position in shares of Establishment Labs by 900.0% during the 2nd quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock worth $85,000 after buying an additional 1,800 shares during the period. CWM LLC raised its stake in shares of Establishment Labs by 45.9% during the second quarter. CWM LLC now owns 2,182 shares of the company’s stock worth $93,000 after buying an additional 686 shares during the last quarter. Brian Low Financial Group LLC acquired a new position in Establishment Labs in the third quarter valued at approximately $223,000. Finally, Patriot Financial Group Insurance Agency LLC boosted its stake in Establishment Labs by 5.8% in the third quarter. Patriot Financial Group Insurance Agency LLC now owns 6,375 shares of the company’s stock valued at $261,000 after acquiring an additional 350 shares during the last quarter. Institutional investors own 72.91% of the company’s stock.

Establishment Labs Stock Down 0.3%

Shares of Establishment Labs stock opened at $74.34 on Wednesday. The company has a market capitalization of $2.16 billion, a P/E ratio of -26.18 and a beta of 0.99. The company has a debt-to-equity ratio of 15.06, a current ratio of 3.33 and a quick ratio of 2.10. The business has a 50-day moving average of $70.61 and a two-hundred day moving average of $56.44. Establishment Labs Holdings Inc. has a 1 year low of $26.56 and a 1 year high of $78.24.

Wall Street Analysts Forecast Growth

Several analysts have commented on ESTA shares. Needham & Company LLC reiterated a “buy” rating and set a $84.00 target price on shares of Establishment Labs in a research report on Monday, January 12th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Establishment Labs in a report on Monday, December 29th. BTIG Research increased their target price on Establishment Labs from $81.00 to $86.00 and gave the company a “buy” rating in a research note on Wednesday, December 31st. Citigroup boosted their target price on Establishment Labs from $62.00 to $75.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Finally, JPMorgan Chase & Co. increased their price target on shares of Establishment Labs from $71.00 to $80.00 and gave the company an “overweight” rating in a research report on Wednesday, December 17th. Six investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $78.86.

Establishment Labs Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.